Applied BioSciences Launches Expanded Pet Line Under Herbal Pet
LOS ANGELES (PRWEB) OCTOBER 09, 2018
Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has expanded and launched a hemp derived CBD pet line under the Herbal Pet brand. The products will be sold on Herbal Pet’s new website (http://www.herbalpet.com) and in select locations in the U.S.
Although the health benefits of CBD are now considered well known, one of the challenges of working with CBD is its bitter after taste. Applied Biosciences focused on this common feedback from humans and developed formulations to improve the experience for both humans and pets. Aromas from CBD are strong and to a dog, that level of concentration can be displeasing. To overcome this issue, the product line (including our chews) has been specifically formulated with natural, high protein, human grade chicken meat – our number 1 ingredient.
In addition to CBD, these chews contain several important ingredients that promote good health. The calming support chew consists of super foods (sweet potato and turmeric) as well as antioxidants (organic chamomile) and a natural amino acid (L-Theanine). The mobility support chew also has bone broth, glucosamine, and chondroitin for bone health. It is also grain-free. Importantly, these products contain no synthetic preservatives, no fillers, no Genetically Engineered ingredients (GMO) and no animal feed ingredients.
“Applied BioSciences continues to be at the forefront of the cannabinoid market, first using organically grown plants, without pesticides or herbicides as our main ingredient and now quickly and easily providing consumers with a variety of tinctures, topical creams and alternatives to the growing demand of this space. Our company continues to launch our product lines in select specialty and retail stores, people and pet owners will also be able to visit our websites to find holistic health and wellness alternatives that best suit their lifestyle,” commented Chris Bridges, President of Applied BioSciences Corp.
Applied BioSciences products are USDA-NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC- free. Our products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanicals, herbals and essential oils to further optimize bioavailability.
About Applied BioSciences Corp.
Applied BioSciences Corp. (http://www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.
The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.
Email: ir(at)appliedbiocorp.com or info(at)appliedbiocorp.com
To be added to the Applied BioSciences email distribution list, please email info(at)appliedbiocorp.com with APPB in the subject line.
Facebook @remediplus & @HerbalPetMeds Instagram @remediplus & @herbal_pet Twitter @remediplus & @herbal_pet
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Applied Biosciences Corp. (the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company’s ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.
SOURCE Applied BioSciences Corp.
Released October 9, 2018